StockData

NanoViricides, Inc. (NNVC) stock

NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.16−0.08 (-6.45%)

Close on Nov 17, 2026Market cap $29.61MP/E –Yield –

Earnings

NanoViricides's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of NanoViricides's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

NanoViricides has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When NanoViricides puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases NanoViricides filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?